StonvexLoading…
StonvexStonvexStonvexCore line items from NEWT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2014 2014-09-30 | Q3 2013 2013-09-30 |
|---|---|---|
Revenue | $112.38M | $105.93M |
Operating Income | $9.03M | $7.04M |
Net Income | $5.43M | $5.11M |
EPS (Diluted) | $0.71 | $0.68 |
Total Assets | $203.19M | Not available |
Total Liabilities | $119.95M | Not available |
Cash & Equivalents | $4.40M | $7.76M |
Free Cash Flow OCF − CapEx | $15.02M | $-2.70M |
Shares Outstanding | 7.49M | 7.57M |